Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Lei Du has a total of 171 co-authors. Here are the top co-authors by number of shared publications:

  • Jing Lin

    Department of Anesthesiology, West China Hospital, Sichuan University, China

    12 shared publications
  • Jiyue Xiong

    Sichuan Univ, West China Hosp, Dept Anesthesiol, Chengdu 610041, Sichuan, Peoples R China

    9 shared publications
  • Xinhao Liu

    Department of Anesthesiology, West China Hospital, Sichuan University, Chengdu, China

    7 shared publications
  • Zhong Wu

    Department of Cardiovascular Surgery, West China Hospital, Sichuan University, Chengdu, China

    6 shared publications
  • Changwei Chen

    Department of Anesthesiology, West China Hospital, Sichuan University, Chengdu, China

    5 shared publications
  • Jie Zhang

    Key Laboratory of Transplant Engineering and Immunology, West China Hospital, Sichuan University, No. 37 Guo Xue Alley, Chengdu 610041, China

    5 shared publications

Latest Publications

  • Open Access

    Editorial: Immune cell dynamics and biomarkers in cardiac surgery-induced systemic inflammatory response

    by Jia Tan, Bingyang Ji, Yongfeng Shao, Weixun Duan, Wataru Takayama, Lei Du

    Systemic inflammatory response (SIR) triggered by cardiac surgery under cardiopulmonary bypass (CPB) remains an unresolved challenge leading to multi-organ dysfunction, infection, and increased mortality (1-2) . To alleviate SIR, numerous studies have tried to removal proinflammatory cytokines and neutrophils. Unfortunately, no strategies have yet translated into effective preventive or therapeutic treatment, because of the complex interplay of immune activation (3). This Research Topic was launched to address two interrelated questions: how does immune status shape patient outcomes, and can immune modulation effectively improve prognosis? This topic comprises eight articles, trying to explore potential inflammatory and immune biomarkers and their relationship with immune status and clinical outcomes, as well as evaluating the effectiveness of immunotherapy and perioperative immunomodulation.In this topic, Jia Y et al. found that early low postoperative serum prealbumin was independently associated with pulmonary complications and new-onset atrial fibrillation in patients undergoing off-pump coronary artery bypass grafting. Yu J et al., Aierken K et al., and Li LM et al. independently demonstrated that the systemic immune-inflammation index (SII) and several ratios derived from leukocyte counts and lipid parameters are associated with mortality, stroke progression, and in-hospital death. Maisat W et al. demonstrated marked postoperative remodeling of gene expression in pediatric patients undergoing CPB. Downregulation of myo5c correlated consistently with organ dysfunction scores, interleukin-6 (IL-6) levels, and markers of neutrophil and platelet activation, which may be associated with neutrophil extracellular trap formation. These identified indices derived from routine complete blood counts and biochemical tests are easily accessible, repeatable, and low-cost, making them attractive for clinical risk stratification.The interventional studies in this topic have explored perioperative immune modulation and organ protection. In patients undergoing cardiac surgery, Huang L et al. found that bilateral transversus thoracis plane block improved by dexmedetomidine significantly reduced perioperative stress hormone levels and shortened the duration of mechanical ventilation and ICU stay. In an experimental venoarterial extracorporeal membrane oxygenation (VA-ECMO) model, Chen Y et al. found that early left heart decompression improved oxygenation and hemodynamics, mitigated pulmonary edema, and reduced inflammatory cytokine levels in lung tissue, thereby strengthening the link between mechanical stress, inflammation, and organ injury. Jiefei X et al. demonstrated that intraoperative HA380 blood adsorption for infective endocarditis was associated with shorter hospital stay and more favorable coagulation-inflammation profiles, suggesting that non-specific cytokine removal might improve aspects of the inflammation without impacting main clinical endpoints.Overall, the studies collected in this Research Topic convey two key messages. First, the association between immune status and clinical outcome is beyond doubt, yet existing markers still fall short of enabling precise prediction and targeted intervention. Second, cytokine networks are highly complex, with short half-lives and strong feedback regulation, preventive strategies centered only on cytokines and non-specific anti-inflammatory approaches appear insufficient to substantially improve outcomes. These observations point towards a necessary shift in strategy: from targeting cytokines to targeting cells.At present, there are two main cell-based strategies for treating SIR. Selective Cytopheretic Device (SCD), developed in the United States, was initially designed for patients undergoing CPB, but its relatively low blood flow and processing efficiency led to a shift toward use in dialysis patients. SCD is integrated into the continuous renal replacement therapy (CRRT) circuit and operated under low shear stress and low ionized calcium conditions. It takes advantage of the enhanced adhesiveness of activated leukocytes, which preferentially adhere to the fiber membrane surface. In patients requiring renal replacement therapy, SCD treatment has been shown to improve survival, but it carries a risk of inducing hypocalcemia (4). Another strategy is the Selective Activated Leukocyte Depletion (SALD) device developed in China. This device uses an ultrafine fiber adsorption membrane grafted with RGD peptides (Arg-Gly-Asp), which can selectively bind to specific peptide structures on activated leukocytes and thereby achieve efficient removal of activated leukocytes. In patients undergoing cardiac surgery with CPB, SALD has been shown to reduce activated leukocyte burden (5). Compared with SCD, SALD is simple to use and efficient to remove the activated leukocytes. Now, both of them are being conducted in accordance with Good Clinical Practice (GCP), and we expect they would bring good news for lower organs dysfunction and lower mortality.Building on these insights, perioperative immune phenotyping may be used to identify patients most likely to benefit from immunotherapy, followed by the selective adsorption or modulation of specific immune cell subsets to reprogram their functional states rather than simply lowering mediator levels. We believe that only when immune monitoring, risk stratification, and therapeutic strategies form a closed loop will it be possible to achieve a genuine breakthrough in the management of SIR. The studies presented in this Research Topic lay an important foundation for this goal and provide clear direction for future clinical and translational research on immune cells in the perioperative setting.All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may...

  • Open Access

    Perioperative Profiles of Immune Cells in Patients with Postoperative Delirium After Cardiac Surgery with Cardiopulmonary Bypass

    by Juan Wu, Zhenzhen Cheng, Xinyi Liao, Ping Yang, Qinjuan Wu, Tingting Wang, Wentong Meng, Zongcheng Tang, Lei Du

    Background: Postoperative delirium (POD) is known to involve systemic inflammatory responses, but the characteristics of the immune cell types involved in these responses are unclear. Methods: In this prospective study, we compared relative abundances and transcriptomes of circulating immune cells between patients who experienced POD (n = 11) or not (n = 109) within 7 days after elective cardiac surgery with cardiopulmonary bypass. Blood was sampled before and at 24 h after surgery; features of immune cells were profiled using multi-channel spectral flow cytometry, 10× single-cell RNA sequencing, and measurement of plasma levels of cytokines. Results: Patients with POD were older and with higher incidence of congestive heart failure than patients without POD, and these risk factors in turn positively correlated with preoperative proportion of CD40+/HLA-DR+ monocytes and CD69+CD8+ T cells. In addition, preoperative activation of antigen presentation in monocytes and chemotaxis in CD8+ T cells, as well as elevated plasma levels of chemokines CCL3 and CXCL8, were detected in patients with POD. After cardiac surgery, activation of antigen presentation and chemotaxis were also found in patients with POD. Conclusions: This study described the perioperative landscape of immune cells in POD and found possible links between preoperative immune dysfunction and risk factors, which may guide future research to explore how the immune system contributes to POD and to design preventive strategies.


  • MedICL: In-Context Learning for Semantically Enhanced AKI Prediction in Cardiac Surgery

    by Chenyang Su, Yishun Wang, Boqiang Xu, Rong Feng, Lei Du, Hongbin Liu, Gaofeng Meng


  • Open Access

    2024 Guidelines on Patient Blood Management for Adult Cardiac Surgery Under Cardiopulmonary Bypass in China

    by Shujie Yan, Li Zhou, Chen Chen, Yuan Teng, Gang Liu, Luyu Bian, Jingjing Su, Hongwen Ji, Feilong Hei, Sheng Wang, et al.

    The Working Group on Cardiopulmonary Bypass and Extracorporeal Life Support of China National Center for Cardiovascular Quality Improvement presents evidence-based guidelines on patient blood management for adult cardiac surgery under cardiopulmonary bypass. These guidelines aim to promote patient blood management programs, reduce blood loss and allogeneic transfusion, and improve patient outcomes. The Guidelines Panel includes multidisciplinary experts. Based on prior investigation and the patient, intervention, comparison, outcome (PICO) principles, thirteen questions from four aspects were selected, including priming and fluid management during cardiopulmonary bypass, anticoagulation and monitoring during cardiopulmonary bypass, peri-cardiopulmonary bypass blood product infusion, and autologous blood infusion. Systemic reviews of the thirteen questions were performed through literature research. Recommendations were generated using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) system and reviewed and refined by all the Guideline Panel members. A total of 19 recommendations were finally approved after five expert meetings between 2023 and 2024. By implementing these recommendations, perfusionists and medical staff involved in cardiac surgery can optimize patient blood management, effectively decrease allogeneic blood transfusion rates, minimize perioperative bleeding, and ultimately improve the prognosis in adult patients undergoing cardiac surgery with cardiopulmonary bypass.


  • Open Access

    Retrograde inferior vena cava perfusion reduces the risk of acute kidney injury depending on the oxygen extraction ratio. A retrospective cohort study

    by Xinyi Liao, Dan Luo, Jing Lin, Zhaoxia Tan, Jiyue Xiong, Lei Du

    Background: Total aortic arch replacement surgery (TARS) for Acute type A aortic dissection is associated with high incidence of postoperative acute kidney injury (AKI), at least partly due to the lower body ischemia during circulatory arrest. This study aimed to evaluate whether retrograde inferior vena cava perfusion (RIVP) reduces the risk of AKI by providing oxygenated blood to the lower body.Methods: This retrospective study utilized a medical recording system to screen patients who underwent TARS from January 1 to December 31, 2019. Patients were assigned to receive antegrade cerebral perfusion (ACP) only or ACP + RIVP during circulatory arrest. The primary outcome was postoperative AKI. Oxygen delivery, consumption, and extraction ratio during RIVP were also determined.Results: Of all included 87 patients, postoperative AKI occurred in 35 (40%), of whom 23 (53.5%) were in the ACP, and 12 (27.3%) were in the ACP + RIVP (P = 0.013). In regression analysis, ACP + RIVP was associated with lower risk of AKI than ACP alone (adjusted OR 0.229; 95% CI 0.071–0.746). RIVP at a pressure of 22.5 ± 3.8 mmHg delivered 0.98 ± 0.34 ml/min/kg of oxygen to the lower body, and the partial oxygen pressure decreased from 359 ± 57 mmHg in RIVP blood to 64 ± 30 mmHg in returning blood. Oxygen extraction ratio was 44 ± 16%, which correlated negatively with peak postoperative creatinine levels (r = −0.58, P = 0.01) and creatinine increase (r = −0.61, P = 0.009). No correlations were found between oxygen delivery and postoperative creatinine or creatinine increase.Conclusion: RIVP may reduce the risk of postoperative AKI in a manner that depends on the tissue oxygen extraction ratio.


  • Top Cited Papers
    Open Access

    Development and Validation of a Dynamic Real-Time Risk Prediction Model for Intensive Care Units Patients Based on Longitudinal Irregular Data: Multicenter Retrospective Study

    by Zhuo Zheng, Jiawei Luo, Yingchao Zhu, Lei Du, Lan Lan, Xiaobo Zhou, Xiaoyan Yang, Shixin Huang

    Background: Timely and accurate prediction of short-term mortality is critical in intensive care units (ICUs), where patients’ conditions change rapidly. Traditional scoring systems, such as the Simplified Acute Physiology Score and Acute Physiology and Chronic Health Evaluation, rely on static variables collected within the first 24 hours of admission and do not account for continuously evolving clinical states. These systems lack real-time adaptability, interpretability, and generalizability. With the increasing availability of high-frequency electronic medical record (EMR) data, machine learning (ML) approaches have emerged as powerful tools to model complex temporal patterns and support dynamic clinical decision-making. However, existing models are often limited by their inability to handle irregular sampling and missing values, and many lack rigorous external validation across institutions. Objective: We aimed to develop a real-time, interpretable risk prediction model that continuously assesses ICU patient mortality using irregular, longitudinal EMR data, with improved performance and generalizability over traditional static scoring systems. Methods: A time-aware bidirectional attention-based long short-term memory (TBAL) model was developed using EMR data from the MIMIC-IV (Medical Information Mart for Intensive Care) and eICU Collaborative Research Database (eICU-CRD) databases, comprising 176,344 ICU stays. The model incorporated dynamic variables, including vital signs, laboratory results, and medication data, updated hourly, to perform static and continuous mortality risk assessments. External cross-validation and subgroup sensitivity analyses were conducted to evaluate robustness and fairness. Model performance was assessed using the area under the receiver operating characteristic curve (AUROC), area under the precision-recall curve (AUPRC), accuracy, and F1-score. Interpretability was enhanced using integrated gradients to identify key predictors. Results: For the static 12-hour to 1-day mortality prediction task, the TBAL model achieved AUROCs of 95.9 (95% CI 94.2-97.5) and 93.3 (95% CI 91.5-95.3) and AUPRCs of 48.5 and 21.6 in MIMIC-IV and eICU-CRD, respectively. Accuracy and F1-scores reached 94.1 and 46.7 in MIMIC-IV and 92.2 and 28.1 in eICU-CRD. In dynamic prediction tasks, AUROCs reached 93.6 (95% CI 93.2-93.9) and 91.9 (95% CI 91.6-92.1), with AUPRCs of 41.3 and 50, respectively. The model maintained high recall for positive cases (82.6% and 79.1% in MIMIC-IV and eICU-CRD). Cross-database validation yielded AUROCs of 81.3 and 76.1, confirming generalizability. Subgroup analysis showed stable performance across age, sex, and severity strata, with top predictors including lactate, vasopressor use, and Glasgow Coma Scale score. Conclusions: The TBAL model offers a robust, interpretable, and generalizable solution for dynamic real-time mortality risk prediction in ICU patients. Its ability to adapt to irregular temporal patterns and to provide hourly updated predictions positions it as a promising decision-support tool. Future work should validate its utility in prospective clinical trials and investigate its integration into real-world ICU workflows to enhance patient outcomes.


  • Open Access

    Specific immune landscape of heatstroke distinguished from sepsis and aseptic inflammation

    by Juan Wu, Zhenzhen Cheng, Sha Yang, Qinjuan Wu, Ping Yang, Xinyi Liao, Tao Cheng, Wenxia Huang, Yuan Zhu, Zongcheng Tang, et al.

    Heatstroke is associated with immune system disturbances, which was similar to sepsis and aseptic inflammation. This study characterized the immune landscape of heatstroke and compared it to sepsis or aseptic inflammation in order to identify heatstroke-specific characteristics. We prospectively recruited 40 patients with heatstroke as well as the same number of age- and sex-matched healthy controls, patients with sepsis, or cardiopulmonary bypass-induced aseptic inflammation. Blood from the four groups was collected to perform spectral flow cytometry, single-cell RNA sequencing and protein chip assay to compare the profiles of T cells, B cells, monocytes, and natural killer cells. In patients with heatstroke, the relative abundance of TLR4+ monocyte was significantly higher than in the other three groups, and activation of antigen presentation and inhibition of chemotaxis were observed in monocytes high expressing TLR4. Both heatstroke and sepsis were characterized by lymphopenia and T cell exhaustion, with T cell exhaustion in particular potentially associated with death and organ injury in heatstroke. The decreased cytotoxic activity of NK cells was also observed in heatstroke. In conclusion, our study described the immunological characteristics of heatstroke, which provided the theoretical basis for exploring the immunotherapy of heatstroke.


  • Open Access

    Development and Validation of a Dynamic Real-Time Risk Prediction Model for Intensive Care Units Patients Based on Longitudinal Irregular Data: Multicenter Retrospective Study (Preprint)

    by Zhuo Zheng, Jiawei Luo, Yingchao Zhu, Lei Du, Lan Lan, Xiaobo Zhou, Xiaoyan Yang, Shixin Huang

    BACKGROUND Timely and accurate prediction of short-term mortality is critical in intensive care units (ICUs), where patients’ conditions change rapidly. Traditional scoring systems, such as the Simplified Acute Physiology Score and Acute Physiology and Chronic Health Evaluation, rely on static variables collected within the first 24 hours of admission and do not account for continuously evolving clinical states. These systems lack real-time adaptability, interpretability, and generalizability. With the increasing availability of high-frequency electronic medical record (EMR) data, machine learning (ML) approaches have emerged as powerful tools to model complex temporal patterns and support dynamic clinical decision-making. However, existing models are often limited by their inability to handle irregular sampling and missing values, and many lack rigorous external validation across institutions. OBJECTIVE We aimed to develop a real-time, interpretable risk prediction model that continuously assesses ICU patient mortality using irregular, longitudinal EMR data, with improved performance and generalizability over traditional static scoring systems. METHODS A time-aware bidirectional attention-based long short-term memory (TBAL) model was developed using EMR data from the MIMIC-IV (Medical Information Mart for Intensive Care) and eICU Collaborative Research Database (eICU-CRD) databases, comprising 176,344 ICU stays. The model incorporated dynamic variables, including vital signs, laboratory results, and medication data, updated hourly, to perform static and continuous mortality risk assessments. External cross-validation and subgroup sensitivity analyses were conducted to evaluate robustness and fairness. Model performance was assessed using the area under the receiver operating characteristic curve (AUROC), area under the precision-recall curve (AUPRC), accuracy, and F1-score. Interpretability was enhanced using integrated gradients to identify key predictors. RESULTS For the static 12-hour to 1-day mortality prediction task, the TBAL model achieved AUROCs of 95.9 (95% CI 94.2-97.5) and 93.3 (95% CI 91.5-95.3) and AUPRCs of 48.5 and 21.6 in MIMIC-IV and eICU-CRD, respectively. Accuracy and F1-scores reached 94.1 and 46.7 in MIMIC-IV and 92.2 and 28.1 in eICU-CRD. In dynamic prediction tasks, AUROCs reached 93.6 (95% CI 93.2-93.9) and 91.9 (95% CI 91.6-92.1), with AUPRCs of 41.3 and 50, respectively. The model maintained high recall for positive cases (82.6% and 79.1% in MIMIC-IV and eICU-CRD). Cross-database validation yielded AUROCs of 81.3 and 76.1, confirming generalizability. Subgroup analysis showed stable performance across age, sex, and severity strata, with top predictors including lactate, vasopressor use, and Glasgow Coma Scale score. CONCLUSIONS The TBAL model offers a robust, interpretable, and generalizable solution for dynamic real-time mortality risk prediction in ICU patients. Its ability to adapt to irregular temporal patterns and to provide hourly updated predictions positions it as a promising decision-support tool. Future work should validate its utility in prospective clinical trials and investigate its integration into real-world ICU workflows to enhance patient outcomes. CLINICALTRIAL

  • Open Access

    Association between perioperative hemoglobin decrease and outcomes of transfusion in patients undergoing on-pump cardiac surgery: An observational study from two Chinese heart centers

    by Junhui He, Xinhao Liu, Li Zhou, Changwei Chen, Jing Liu, Min Yan, Yue Ming, Zhong Wu, Yingqiang Guo, Jin Liu, et al.